Featured content
Why authenticity is key for biopharma leaders
Drawing on more than 20 years in the industry and a few unexpected lessons, CPHI Awards 2026 – Woman of the Year finalist, FUJIFILM Biotechnologies’ President and Chief Operating Officer Maja Pedersen, reflects on how leading as your authentic self produces better outcomes for teams, organisations and patients.
ReportCPHI Milan 2026 preview: key themes and emerging trends
Explore the key themes, technologies and emerging trends shaping pharmaceutical development, manufacturing and commercialisation ahead of CPHI Milan 2026.
ArticleEuropean Pharmaceutical Review Issue 2 2026
EPR Issue 2 includes articles on manufacturing, drug formulation, microbiology, downstream bioprocessing, and more.
OpinionWhat will shape the future of advanced therapies in Europe?
Following his opening keynote at this year’s Advanced Therapies Europe conference in Barcelona, Professor Jacob George, MHRA Chief Medical & Scientific Officer, explores the evolving regulatory landscape for advanced therapy medicinal products.
News
NewsCPHI 2026: Will the EU Biotech Act II address Europe’s biotech gap?
A CPHI 2026 keynote explored the legislative changes needed to keep Europe competitive in the evolving biotech industry, including the upcoming EU Biotech Act II.
NewsCPHI selects 2026 Pharma Awards winners
Honourees span API development, finished formulation, supply chain, sustainable innovation and leadership excellence.
NewsNobel Prize awarded for optogenetics
The 2026 Nobel Prize in Physiology or Medicine award celebrates a key advancement in neuroscience following breakthrough findings from a 2005 research paper.
NewsBayer invests $2.2bn in new Ohio manufacturing facility
Automated, modular manufacturing site to support growth of firm’s oncology, cardiovascular and renal care portfolio.
From our partners
European Pharmaceutical Review Issue 2 2026
EPR Issue 2 includes articles on manufacturing, drug formulation, microbiology, downstream bioprocessing, and more.
Demonstrating airflow integrity and VHP compatibility in automated settle plate monitoring
Download this application note to learn how the MAS-100 Libra® supports automated settle plate exposure while maintaining airflow integrity, first-air conditions and effective VHP decontamination in critical aseptic environments.
European Pharmaceutical Review Issue 2 (2026): Micro/RMM In-Depth Focus
As pharmaceutical microbiology evolves, manufacturers are balancing contamination control, regulatory expectations and the need for faster, more actionable data. This In-Depth Focus explores emerging approaches across microbiological testing, monitoring and rapid methods.
Opinion and interviews
What will shape the future of advanced therapies in Europe?
Following his opening keynote at this year’s Advanced Therapies Europe conference in Barcelona, Professor Jacob George, MHRA Chief Medical & Scientific Officer, explores the evolving regulatory landscape for advanced therapy medicinal products.
How can we ensure consistency in decentralised cell therapy manufacturing?
Following her presentation at Advanced Therapies Europe, Charlotte Serra navigates the complexities of decentralised cell therapy manufacturing.
- Previous
- Next
Join now
Unlock exclusive industry insights
- Bookmark articles and resources to access anytime
- Enjoy free access to industry leading resources, webinars and insights
- Stay informed with the latest news and breakthroughs in drug discovery
- Receive updates and recommendations tailored to your research interests
Upcoming Webinars
Webinar
From passive to active air monitoring in aseptic filling: a risk-based approach to replacing settle plates
In this webinar, Particle Measuring Systems will share a case study of a biopharmaceutical company developing and applying a structured global rationale for the implementation of continuous viable environmental monitoring with a single-use microbial impactor within aseptic manufacturing environments.
Webinar
The impact of negative control stability on recombinant endotoxin testing
Discover how PYROSTARâ„¢ Neo+ supports stable negative control (NC) performance for sensitive and precise recombinant endotoxin testing.
Webinar
Building quality and consistency into accelerated cell and gene therapy development
How can cell and gene therapy manufacturers move programmes forward faster without compromising quality, scalability or regulatory readiness?
From passive to active air monitoring in aseptic filling: a risk-based approach to replacing settle plates
The impact of negative control stability on recombinant endotoxin testing
Building quality and consistency into accelerated cell and gene therapy development
On-demand Webinars
- Previous
- Next
